Tradestie Institutional Equity Comparison Engine
VVOS vs TCMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TCMD Overall Edge
TCMD Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tactile Systems Technology, Inc. (TCMD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VVOS trades at N/M Forward P/E with -107.9% operating margin (+34.9% YoY revenue) versus TCMD at 17.4x Forward P/E and 9.4% operating margin (+7.1% YoY). In options structure, VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against TCMD sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
TCMD
VVOS N/M vs TCMD 17.4x Fwd P/E
Growth & Margin Winner
TCMD
Op Margin -107.9% vs 9.4% ยท YoY +34.9% vs +7.1%
Momentum & Technical Winner
TCMD
1Y -97.7% vs +5.7% ยท 52W Pos 0% vs 29%
Options & Structure Winner
TCMD
BREAKDOWN (N/A IV) vs CONSOLIDATION (15th %ile IV)
VVOS
NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap
$1.9M
1M Return
-59.25%
1Y Return
-97.71%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 25.0
Fund 35.0
Flow 50.0
Mom 30.0
TCMD
NASDAQ
Tactile Systems Technology, Inc.
Surgical & Medical Instruments & Apparatus
$25.60
-1.5% 1D
Market Cap
$582.2M
1M Return
+8.75%
1Y Return
+5.65%
Forward P/E
17.4x
Unified AI Score
40.1 / 100
SELL
Tech 37.0
Fund 44.0
Flow 65.0
Mom 31.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VVOS -97.71%
TCMD +5.65%
Spread: +103.36 pp (TCMD Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VVOS Revenue | TCMD Revenue | VVOS Op. Margin | TCMD Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $140M | N/A | 2.1% | TCMD |
| FY2019 | $10M | $190M | -92.8% | 5.5% | TCMD |
| FY2020 | $10M | $190M | -92.1% | -1.9% | TCMD |
| FY2021 | $20M | $210M | -120.7% | -0.8% | TCMD |
| FY2022 | $20M | $250M | -156.2% | -5.2% | TCMD |
| FY2023 | $10M | $270M | -125.3% | 6.6% | TCMD |
| FY2024 | $20M | $290M | -74.3% | 7.6% | TCMD |
| FY2025 | $20M | $330M | -114.1% | 8.9% | TCMD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VVOS | TCMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.9M | $582.2M | Larger Scale | TCMD |
| Trailing P/E Ratio Valuation | N/M | 25.2x | Lower Multiple | TCMD |
| Forward P/E Ratio Valuation | N/M | 17.4x | Lower Multiple | TCMD |
| Revenue Growth (YoY) Growth | +34.9% | +7.1% | Higher Growth | VVOS |
| Operating Margin (TTM) Profitability | -107.9% | 9.4% | Higher Margin | TCMD |
| Net Profit Margin Profitability | -121.8% | 6.7% | Higher Margin | TCMD |
| Return on Equity (ROE) Capital Efficiency | -8585.3% | 11.0% | Higher ROE | TCMD |
| 52-Week Range Position Momentum | 0% ($0โ$3) | 29% ($21โ$38) | Stronger Trend | TCMD |
| Beta / 30D Volatility Risk Regime | 1.70ฮฒ ยท 111% Vol | 0.95ฮฒ ยท 52% Vol | Lower Realized Risk | TCMD |
| Unified Institutional Score Composite Signal | 36.4 / 100 (SELL) | 40.1 / 100 (SELL) | Higher Composite | TCMD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VVOS vs TCMD Buy Guide
VVOS
BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
TCMD
CONSOLIDATION
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VVOS nor TCMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.